{"name":"Covagen","slug":"covagen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQVlpMd0k3ZVVjanRwUnA4UmtVcVVWajIyakt5dVJxbXpQaUt6eWoyMFBBTEtuWnAwdUlyNGVMbzJFVHN1YUhUMnhXdFcxS21SX2JDS1MxOE9XMFBfV1VSM0VYSWZpZWZYNGxiSlBVQ0hTWXhRLTdYQWVrRGw0Qmw0dEZrZEY5dnFHUEo3STVHNkczcUR3blhaVm9aeE5TYlhLeERTT2JsOXRJSnZ3bXF5LTFBRnJVWkw0NDRoY1FGWFI5UDZ0cVZCczdNd0x6ZDdWZUVtWE1OT3BnTGM5VFhvSFJnOThDZ0FFWllsbF9DSTUwNWZTbXc?oc=5","date":"2021-10-20","type":"pipeline","source":"European Medical Journal","summary":"Efficacy and Safety of Monoclonal Antibody Therapies in Patients with Moderate-to-Severe Plaque Psoriasis - European Medical Journal","headline":"Efficacy and Safety of Monoclonal Antibody Therapies in Patients with Moderate-to-Severe Plaque Psoriasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9qd0ZlcTJYUGxNMFJnNkFYbUlRT2I3dXc1SzJrWU1CS0d1bmRaZ1RKYTZYVzcxckxvaGhTaUhySDA3amVILU1HaVJaS3U1M3p6N2FvcldtaUc1V2taTGdITXNwN195eWJsRWlqXw?oc=5","date":"2021-06-02","type":"pipeline","source":"Wiley Online Library","summary":"Journal of the European Academy of Dermatology and Venereology - Wiley Online Library","headline":"Journal of the European Academy of Dermatology and Venereology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNVFBwaFFvaFVyZnM5OXIxZEVLMnkzVVN0cEwyTUV3aVNhVWpETm95Qy1KWEtpSldXZGl6WVJsbmdobzVla2Y2TFNsc2lOMU0tMG9KNkkzdlI4Ny1EYlBQSTliRV80eFRuaF9QNGgtbFBuekZXVUVhcEE5ZHY2bUpmTld5ZzdLYjNzc0VCSFZqY0FrSGhkWlV1dERwblF3VW12U3ZHS1E5Q3BjUGt0TTNKckkzeWZsWlJH?oc=5","date":"2020-12-15","type":"pipeline","source":"European Medical Journal","summary":"The Other Side of the Moon: A Clinical Dialogue on the IL-23 Pathway - European Medical Journal","headline":"The Other Side of the Moon: A Clinical Dialogue on the IL-23 Pathway","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNbFk1Qjc4d1NTVzY4Y0RuR1U3R3gyTlB0bmlJQmtNc3BJQkhEbFZyWU5mVF9RaXFrRXFTNTE3N0lqcTY5bl9KZm9JVTdBY1AxUkdmNXYxbnBtQ3pOdkVKZXNtTWZ1Q0tlVmpTUnpWUXkydkZHSHVZSFFqcTNmM0xvWDNfbGprOXVQRmhfQ1dlZkNjLTFGLVpJUlRKeWpnbUJpSWRTTUJuQzB0ZUdWVXVCQlVPczZKdTg5ZE5RdnExaEpnZw?oc=5","date":"2020-07-21","type":"pipeline","source":"European Medical Journal","summary":"Advancing the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway - European Medical Journal","headline":"Advancing the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxObWRBams0VTNOSThsclBMdlRqd2IwR3g2Z0I4cEY2eVZ3WTZsanlGcG90RG1YWkw3RHg4d0lZUkctTUJnX2FxNkUzSEJtRlM4V01qNmlRdDVrUU1iSU1UV3U4ekU1Ym1saXBrZDg3UG1fZzBvMmFTVjFObnY0dzktZjdYU2RBbTU0NHlSdlJTQ3RJWXY2cW83b1NzWmJQMzg3b3BvQjZoSjBLRVZvZUVUTlE0bXF4N3FlRWZzR0piWHdZVnNIa01IX1dITXZZV190cmpwR3NZTUptVV9uakFqMVdKUWRPZld0cFJCakNDUWpjS3VyTERXNzU0cXJwQkQtRVR0X2c3TXMyOW5xM3JCODFVaFVFX3Z0eV84bGlJSnVWLXJERkVpamJxVUVEMU14RXQ5TW9vWQ?oc=5","date":"2020-02-28","type":"trial","source":"European Medical Journal","summary":"Long-Term Safety of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis through 3 Years (148 Weeks) from reSURFACE 1 and reSURFACE 2 Phase III Trials - European Medical Journal","headline":"Long-Term Safety of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis through 3 Years (148 Weeks) from ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNN2JrWVpXYTRTRHg3MXY5MGlMenA1M1FfelZJTFFBRU5hNTl2RlpoZXFzN1JNOTV5TUk4d1RzMWY5WXZ6M2FVel9MVWp5Zy1pSlBZYUhpNUUyMEhJa3VJWnA1cUZNM0pVdTd2UldjdXJlMkNESzdzSldpSkJLdHhRVGNzYmlaVEdkSnVVVEZOR1d3MUFPZDl4azJ0VzFOQWxDelJkM3VoVUR3UjQ2czZtNFNoT05pallQcFBGNDNmaHF6YWkxd05JTFF1TQ?oc=5","date":"2019-09-17","type":"pipeline","source":"European Medical Journal","summary":"IL-23 Inhibition in Psoriasis: A Novel Approach to Convenient, Consistent Clearance - European Medical Journal","headline":"IL-23 Inhibition in Psoriasis: A Novel Approach to Convenient, Consistent Clearance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQOFVCVnRodXJCMkJjaTNqa1NpS0FPdy0yTlBBNTZNeTdzN1RBT0hTTDV1M0FSejJhajNIU0Q4ZzlxZXNVMW5OWHBTRzd2Vnl4ajBSVjJMbWtvLTlCV3FIcFpQSWFtZUNaUmM2OHR0THNBSlUzUFJDdG93bU9DWjJ5UVlKMkUzaTBmODRqcnp4X0VJWEtfRHFPekR3bGJLZVludVBla3VuMjFzMjVjYnJLdWppUE1FZk95ZmNv?oc=5","date":"2018-10-30","type":"pipeline","source":"European Medical Journal","summary":"IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future - European Medical Journal","headline":"IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOSG5xNEhQaHhoZ21mSW1ONDFfdXRFYmVlMFB3X1V6WGZwTG1DSnBxUXBFTWQ1NGI4dUFBSG5MYWdkUVNESG5lVEJXd1YyaUl5ZVR4OWMzamNWZ3ZibFFnWGhDYjRnNU9CQURHQndJSEZ5aXNLa09KYi1JTWJzQ2RrQlYtZ3BVblJvR3czN3lVdlBjQi1HVHgxV3dUeHZZeXMtZmc?oc=5","date":"2018-10-30","type":"pipeline","source":"European Medical Journal","summary":"Is Complete Skin Clearance in Psoriasis the Answer? - European Medical Journal","headline":"Is Complete Skin Clearance in Psoriasis the Answer?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNSWp1ZXJFNTdKOHltTnllTjRQMXVISzc4eFl1SThKT1UzejBqV0p5TG9CODhIcmMtajJ1d2szWnlHV1VOdmZxcWZwN0hVUHVHdUtKYjZ3NW13VVJVMlh5VnA0OUNJV3E4UlNyX3IzMHFkQVYwdThNZU5xTTluV3RPa3VDQzBIM3RyZGpZYjY0S21BMS1pLWpwNGczVENtUzhpdE41WUxuZ1p3ZVJRTFIwUFA1U1d2cmd6anh2OEljLXRoemNybmk2d0JvZGd3eTlnOXgwZQ?oc=5","date":"2018-03-01","type":"pipeline","source":"European Medical Journal","summary":"Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape - European Medical Journal","headline":"Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE81bHBPVDEweGZvY2tfV3FBbzIzMndVaTF2RVZxNnM5emEwZGdNZ2VDMUxhR0REeVNpZmtYaWNhMUR6N1J1VXVrVFM0d3Y0bTA5VmhwQ3Rqd2xud01hay0waVc2Q0ZvS3ByS3ktdUpZYS1vS3puakE?oc=5","date":"2014-08-26","type":"deal","source":"BioPharma Dive","summary":"J&J’s Janssen buys Covagen - BioPharma Dive","headline":"J&J’s Janssen buys Covagen","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}